Embedded Files
Why NeuroPath exists
Why NeuroPath exists
In 2024, a conversation outside the lab changed the direction of our work.
A friend told our founder something no parent should ever have to say:
“My daughter is hurting herself — and no one knows why.”
“My daughter is hurting herself — and no one knows why.”
What stood out wasn’t only her distress. It was the absence of any objective way to detect escalating risk before it became a crisis.
NeuroPath was founded to close that gap.
How NeuroPath Makes Risk Visible
NeuroPath combines a short behavioural check-in, a finger-prick blood sample and AI analysis to give clinicians an objective signal they can act on.
Built through science, technology & collaboration
NeuroPath brings together academic expertise, enabling technology and a growing innovation ecosystem to develop and scale its approach.
Built on evidence, shaped by clinicians
NeuroPath’s approach is grounded in published biomarker research and informed by direct conversations with the clinicians who make mental-health triage decisions every day.
50+ GP interviews
50+ GP interviews
One consistent message: clinicians need an objective, time-efficient way to identify escalating risk and prioritise referrals.
Biological foundation
Biological foundation
A targeted biomarker panel informed by convergent metabolomic evidence associated with emotional distress and self-harming behaviour.
Designed for clinical use
Designed for clinical use
A short behavioural check-in, finger-prick blood sample and AI analysis combined into one actionable clinical signal.
Help make self-harm risk visible before crisis
NeuroPath is building the evidence, technology and partnerships needed to bring objective biology into mental-health decision-making.
You can help move intervention earlier—before distress becomes crisis.
Page updated
Google Sites
Report abuse